Does LAPATINIB DITOSYLATE Cause Performance status decreased? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Performance status decreased have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 0.2% of all adverse event reports for LAPATINIB DITOSYLATE.
8
Reports of Performance status decreased with LAPATINIB DITOSYLATE
0.2%
of all LAPATINIB DITOSYLATE reports
2
Deaths
6
Hospitalizations
How Dangerous Is Performance status decreased From LAPATINIB DITOSYLATE?
Of the 8 reports, 2 (25.0%) resulted in death, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Performance status decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAPATINIB DITOSYLATE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does LAPATINIB DITOSYLATE Cause?
Diarrhoea (893)
Death (665)
Nausea (317)
Fatigue (301)
Vomiting (259)
Rash (249)
Drug ineffective (183)
Malignant neoplasm progression (183)
Off label use (141)
Disease progression (137)
What Other Drugs Cause Performance status decreased?
BACLOFEN (156)
LENALIDOMIDE (118)
PACLITAXEL (112)
BEVACIZUMAB (103)
SODIUM OXYBATE (103)
CARBOPLATIN (100)
DEXAMETHASONE (80)
CAPECITABINE (75)
NIRAPARIB (75)
LUMATEPERONE (68)
Which LAPATINIB DITOSYLATE Alternatives Have Lower Performance status decreased Risk?
LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
LAPATINIB DITOSYLATE vs LARONIDASE
LAPATINIB DITOSYLATE vs LAROTRECTINIB
LAPATINIB DITOSYLATE vs LASILIX
LAPATINIB DITOSYLATE vs LASIX